Mucolipidosis 11 (1-cell disease) is a fatal neurodegenerative disorder which is clinically similar to the mucopolysaccharidoses and is inherited as an autosomal recessive condition (McKusick et al., 1978) . Skin fibroblasts from these patients have numerous membranous inclusion bodies, which appear to be lysosomes. Although the primary defect has not been described, several biochemical features of this disorder have been reported. In cultured skin fibroblasts from patients with mucolipidosis II, there is a marked intracellular decrease in most lysosomal enzyme activities, with a concomitant increase of these activities in the culture media; similarly, plasma activities of most hydrolases are significantly elevated (Weisman et al., 1974) . Although no major specific substrate appears to be accumulating in these patients, a generalized increase of sialic acid along with a marked decrease in aneuraminidase (EC 3.2.1.18) activity has been found in fibroblasts from mucolipidosis-II patients (Thomas et al., 1976) . Early observations of a decreased capacity of several hydrolases of mucolipidosis-II patients to be endocytosed by normal fibroblasts (Hickman & Neufeld, 1972) , and altered electrophoretic mobilities of many hydrolases of mucolipidosis-II patients (Champion & Shows, 1977) , have suggested that the defect in mucolipidosis II results in a generalized alteration of lysosomal hydrolases, perhaps through defective post-translational processing. Although treatment of hexosaminidase from fibroblasts of mucolipidosis-II patients with neuraminidase did not alter its uptake by normal fibroblasts (Vladutiu & Ratazzi, 1978) , the electrophoretic mobility of this enzyme appeared to return to normal. Finally, a somewhat lower Vol. 180 capacity of liver 16-galactosidase to be bound by immobilized concanavalin A has also been reported (Miller, 1978) , suggesting in conjunction with several of the above results that the defect in mucolipidosis II may result in altered post-translational glycosylation of lysosomal hydrolases. In addition to these observations, evidence has been presented suggesting that the defect in mucolipidosis II may also result in an altered membrane structure (Sly et al., 1976) .
In order to examine further the possibility that enzymes in mucolipidosis II may be undergoing faulty glycosylation processes, we have utilized a sensitive system of titration to the binding of eight hydrolase activities, before and after neuraminidase treatment, to two immobilized lectins (concanavalin A and wheat-germ agglutinin) which are known to bind a large number of lysosomal enzymes through their carbohydrate moieties (Fiddler et al., 1979) .
Materials and Methods
Fibroblasts were derived, after obtaining informed consent, from skin biopsies of five normal controls, two patients with mannosidosis and three with mucolipidosis II. The cells were cultivated and harvested as previously described (Ben-Yoseph et al., 1977) . Activity of lysosomal hydrolases towards synthetic 4-methylumbelliferyl substrates (KochLight, Colnbrook, Bucks., U.K.) were assayed as previously described (Fiddler et al., 1979) Wheat-germ agglutinin (ug) Fig. 2 . Titration of fl-N-acetylhexosaminidase activity from fibroblasts of normal controls (e, 0) and patients with mucolipidosis IH (A, A) before (e, A) and after (0, A) neuraminidase treatment by immobilized wheat-germ agglutinin Initial enzymic activity (nmol/h) in diluted lysates from normal subjects and mucolipidosis-II patients: 559 and 622 respectively. activity of mucolipidosis-II patients which was closer to that of the untreated normal activity.
The same curves, as illustrated in Figs. 1 and 2, were obtained even if the initial activities were 10 times more diluted or concentrated.
Similar differences in the titration curves were observed for other acidic hydrolases. Table 1 presents a summary of the data obtained for eight hydrolase activities titrated with immobilized concanavalin A and five activities titrated with immobilized wheat-germ agglutinin. The intracellular values of these hydrolase activities in fibroblasts from patients with mucolipidosis II ranged from 2.3 % of control for a-fucosidase to 125 % of control for acid phosphatase. However, for all eight activities marked differences were observed for the quantity of lectin required to bind 50% of the activity in fibroblast lysates of mucolipidosis-II patients compared with normal cell lysates. For concanavalin A, the ratio of lectin (w/w) required to remove half of the activity from lysates of mucolipidosis-II patients compared with normal lysates before neuraminidase treatment ranged from 3.0 for fJ-glucosidase to over 14 for acid phosphatase.
Neuraminidase treatment markedly decreased all the ratios to below 1.0. Similar results were obtained from those intracellular hydrolases titrated with wheat-germ agglutinin. In addition, several hydrolases, including ac-mannosidase from fibroblasts, obtained from two patients with mannosidosis provided results similar to these for normal fibroblasts.
Finally, examination of one of these hydrolases, fl-galactosidase, from both untreated and neuraminidase-treated lysates of normal subjects and patients with mucolipidosis II by double diffusion against an anti-(GMl-ganglioside fi-galactosidase) serum prepared against the normal human enzyme revealed no discernible antigenic differences between the 16-galactosidases of normal subjects and mucolipidosis-1I patients.
Discussion
The technique of lectin titration enabled us to detect differences between fibroblasts of patients with mucolipidosis II and control fibroblasts.
Previous studies of the binding of f6-galactosidase from liver of mucolipidosis-Il patients and normal subjects by column chromatography on Sepharosebound concanavalin A revealed no differences in one case (Holmes et al., 1975) and as much as 31-37 % decrease in binding for another patient with mucolipidosis II (Miller, 1978) . We have observed 25-45 % decrease in binding of all enzymes examined by both lectins. The specific binding of glycoproteins to concanavalin A and wheat-germ agglutinin is influenced by the presence and accessibility within the oligosaccharide chain of mannose or N-acetylglucosamine residues, respectively. The lower binding of lysosomal hydrolases from patients with mucolipidosis II to concanavalin A and wheat-germ agglutinin indicates a possible change in the number, the availability or the orientation of carbohydrate residues in these enzyme molecules (Sharon & Lis, 1972; Goldstein & Hayes, 1978) . The method of lectin titration appears to be an effective means of detecting differences between normal hydrolases and hydrolases of mucolipidosis-II patients over a wide range of glycoprotein concentration. This point is emphasized by the experiments using fibroblasts from mannosidosis patients, which are known to contain mannose-rich glycopeptides, the concanavalin A-specific carbohydrate; no differences in hydrolase binding were observed from these three fibroblast lines compared with normal controls. This experiment, however, does not definitively rule out the possibility that other glycoproteins or glycolipids in cells of mucolipidosis-II patients are altering the binding of the hydrolases. These changes may be consistent with many of the altered properties reported, such as 'recognition' markers (Hickman et al., 1974) , sialylation (Thomas et al., 1976) and electrophoretic mobility (Champion & Shows, 1977) . This alteration, however, does not seem to affect the activity of the enzyme protein. In previous studies of GM,-ganglioside f-galactosidase (Ben-Yoseph et al., 1977) and galactosylceramide /1-galactosidase (EC 3.2.1.46) (Ben-Yoseph et al., 1978) from fibroblasts of patients with mucolipidosis II we have shown that the deficient intracellular activity is accompanied by a similar deficiency of antigenically cross-reacting material, and thus normal specific activity of cross-reacting material is retained by these enzymes in mucolipidosis II. After neuraminidase treatment the differences in binding to lectins of lysosomal hydrolases from mucolipidosis-II patients and normal subjects were much less remarkable than for untreated hydrolases. Deficiency of neuraminidase has been suggested as a defect in mucolipidosis II (Strecker & Michalski, 1978) , but the effect of the Clostridium enzyme could not be attributed to a simple 'correction' of this deficiency. This may be the result of differences in substrate specificities between human and the bacterial neuraminidases, but it should be noted that only slight differences were found in enzymes from mucolipidosis-I1 patients, whereas major changes after neuraminidase treatment were seen in the normal enzymes. These observations suggest, however, that sialic acid residues have an important role in determining the conformation of carbohydrate moieties within the lysosomal enzymes, although no antigenic differences could be detected for GM1-ganglioside f,-galactosidase of mucolipidosis-I1 patients and normal subjects before and after neuraminidase treatment.
The most consistent finding in fibroblasts of patients with mucolipidosis II is a decrease in the intracellular activity of lysosomal hydrolases. The degree of deficiency varies with the enzyme, and the relationship of this variation to the molecular defect is not understood. We have studied the binding by lectins of three groups of lysosomal hydrolases with respect to their intracellular activity: A, fl-Nacetylhexosaminidase, a-mannosidase and fl-glucuronidase with lower activities (12-25 %Y of normal); B, fl-galactosidase and a-fucosidase with severely depressed activity (2-10% of normal); C, fl-glucosidase, acid phosphatase and a-glucosidase with nearly normal activities. The abnormal binding by concanavalin A and wheat-germ agglutinin was found for all these enzyme groups before and after neuraminidase treatment. These findings suggest that a general alteration in carbohydrate composition of lysosomal hydrolases may be involved in the process of mucolipidosis II.
